Attainment of therapeutic vancomycin level within the first 24 h: Authors' response

Attainment of therapeutic vancomycin level within the first 24 h: Authors' response

Bibliographic Details
Main Authors:	João Pedro Baptista, Jason A. Roberts, Eduardo Sousa, Ricardo Freitas, Nuno Devesa, Jorge Pimentel
Format:	Article
Language:	English
Published:	BMC 2019-11-01
Series:	Critical Care
Online Access:	http://link.springer.com/article/10.1186/s13054-019-2639-7

Similar Items

Attainment of therapeutic vancomycin level within the first 24 h
by: Patrick M. Honore, et al.
Published: (2019-06-01)

Vancomycin dosing and target attainment in children
by: David Hwang, et al.
Published: (2017-08-01)

Initiation of Vancomycin Therapy and the First Therapeutic Drug Monitoring
by: Mauliņa Inga, et al.
Published: (2021-02-01)

Target Attainment and Clinical Efficacy for Vancomycin in Neonates: Systematic Review
by: Marta Mejías-Trueba, et al.
Published: (2021-03-01)

Advances in the therapeutic monitoring of vancomycin concentrations
by: Kristina Nadrah
Published: (2011-08-01)

Discrepancy in Vancomycin AUC/MIC Ratio Targeted Attainment Based upon the Susceptibility Testing in Staphylococcus aureus
by: Seenae Eum, et al.
Published: (2016-09-01)

Drug Evaluation of Vancomycin in Therapeutic Drug Monitoring
by: Shu-Chen Tsai, et al.
Published: (2012)

Iterative Chemical Engineering of Vancomycin Leads to Novel Vancomycin Analogs With a High in Vitro Therapeutic Index
by: Nigam M. Mishra, et al.
Published: (2018-06-01)

Linezolid and Vancomycin Resistant Enterococci: A Therapeutic Problem
by: Garima Yadav, et al.
Published: (2017-08-01)

Therapeutic monitoring of vancomycin = Monitorização terapêutica da vancomicina
by: Sergio Seiji Yamada, et al.
Published: (2012-07-01)

Population Pharmacokinetics of Vancomycin and Meropenem in Pediatric Extracorporeal Membrane Oxygenation Support
by: Brenda Zylbersztajn, et al.
Published: (2021-08-01)

Authority and How to Attain It: Pausanias, Description of Greece and Archaeological Excavations at Olympia
by: Vladimir V. Mihajlović
Published: (2019-11-01)

BAYESIAN-DERIVED VANCOMYCIN AUC24H THRESHOLD FOR NEPHROTOXICITY IN SPECIAL POPULATIONS
by: Ho, Dan
Published: (2021)

Guidelines for therapeutic drug monitoring of vancomycin: a systematic review.
by: Zhi-Kang Ye, et al.
Published: (2014-01-01)

Therapeutic drug monitoring of vancomycin in an obese patient with renal insufficiency
by: Said Abuhasna, et al.
Published: (2011-01-01)

First Detection of Vancomycin Resistant Enterococcus faecium in Latvia
by: Rudzīte Dace, et al.
Published: (2009-01-01)

Vancomycin Susceptibility within Methicillin-resistant Staphylococcus aureus Lineages
by: Robin A. Howe, et al.
Published: (2004-05-01)

Therapeutic drug monitoring of vancomycin in patients with infectious complications in traumatology and orthopedics
by: Borisov A.M., et al.
Published: (2020-03-01)

Therapeutic Success of Rifaximin for Clostridium difficile Infection Refractory to Metronidazole and Vancomycin
by: George Tannous, et al.
Published: (2010-09-01)

Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections
by: Cui Longzhu, et al.
Published: (2007-10-01)

Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients
by: Dae Il Kim, et al.
Published: (2010-12-01)

Author Index for Volume 24
Published: (2006-12-01)

Attainment of therapeutic posaconazole serum levels during co-administration with rifampicin
by: Nicholas Power, et al.
Published: (2020-12-01)

Continuous-Infusion Vancomycin in Neonates: Assessment of a Dosing Regimen and Therapeutic Proposal
by: Manon Tauzin, et al.
Published: (2019-05-01)

Application of Pharmacometrics in Pharmacotherapy: Open-Source Software for Vancomycin Therapeutic Drug Management
by: Soo Hyeon Bae, et al.
Published: (2019-05-01)

The Therapeutic Drug Monitoring of Vancomycin for the Patients with Hemodialysis in a Medical Center in Taiwan
by: Ming-Shyan Wang, et al.
Published: (2009)

141 Continuous infusion of vancomycin improved therapeutic levels in term and preterm infants
by: Khuen Foong Ng, et al.
Published: (2021-04-01)

Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations
by: Joaquim António Faria Monteiro
Published: (2021)

Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis.
by: Zhi-Kang Ye, et al.
Published: (2013-01-01)

Eradication of Vancomycin-Resistant Enterococci by Combining Phage and Vancomycin
by: Mor Shlezinger, et al.
Published: (2019-10-01)

Advocacy: A Vital Step in Attaining Full Practice Authority for the Advanced Practice Registered Nurse
by: Cafasso, Mandi
Published: (2015)

Uncommon vancomycin: induced side effects
by: Jaime Luís Lopes Rocha, et al.

Uncommon vancomycin: induced side effects
by: Rocha Jaime Luís Lopes, et al.
Published: (2002-01-01)

Polygenic Influence on Educational Attainment
by: Benjamin W. Domingue, et al.
Published: (2015-08-01)

Catching up to girls: Understanding the gender imbalance in educational attainment within race
by: Aucejo, E.M, et al.
Published: (2019)

First-time Beginning Student Attainment: Examining the Role of Distance Education
by: McKean, James R.
Published: (2011)

Investigation of the Vancomycin-Affected Proteins in Vancomycin-Resistant Staphylococcus aureus
by: Wei Ting Jiang, et al.
Published: (2008)

Cathelicidin-Derived Synthetic Peptide Improves Therapeutic Potential of Vancomycin Against Pseudomonas aeruginosa
by: Imran Mohammed, et al.
Published: (2019-09-01)

Achievement of Vancomycin Therapeutic Goals in Critically Ill Patients: Early Individualization May Be Beneficial
by: Bita Shahrami, et al.
Published: (2016-01-01)

Vancomycin-Resistant Enterococci (VRE) in Nigeria: The First Systematic Review and Meta-Analysis
by: Yusuf Wada, et al.
Published: (2020-09-01)